INTERNATIONAL PATENT: EIKON THERAPEUTICS, INC. FILES APPLICATION FOR "PYRIDOPYRIMIDINE AND QUINAZOLINE DERIVATIVES AS USP1 INHIBITORS, COMPOSITIONS COMPRISING THEM AND METHODS OF USING THE SAME"

GENEVA, June 25 -- EIKON THERAPEUTICS, INC. (3929 Point Eden WayHayward, CA 94545) filed a patent application (PCT/US2024/060138) for "PYRIDOPYRIMIDINE AND QUINAZOLINE DERIVATIVES AS USP1 INHIBITORS, COMPOSITIONS COMPRISING THEM AND METHODS OF USING THE SAME" on Dec 13, 2024. With publication no. WO/2025/129076, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ALLEGRETTI, Paul Andrew (c/o Eikon Therapeutics, Inc.3929 Point Eden WayHayward, CA 94545), BECK, Hilary Plake (c/o Eikon Therapeutics, Inc.3929 Point Eden WayHaywar...